[EDI-L Mailing List Archive Home] [Message List] [Reply To This Message]

RE: HIPAA 834 Response

From: "David Frenkel" <gefeg@...>
Date: Wed Sep 3, 2003  8:25 pm
Subject: RE: [EDI-L] HIPAA 834 Response
Jeffery,
Your actions somewhat depend on the capabilities of your trading
partners being able to accept the EDI transactions you mentioned. If I
were to guess they probably would not be able to accept them and if they
did they would do a rip and read. I would stick to the KISS theory and
use the technology sitting on the corner of your desk (telephone) to
handle 834 problems.

Regards,

David Frenkel
612-237-1966

-----Original Message-----
From: Jeffery McCann [mailto: Sent: Wednesday, September 03, 2003 3:14 PM
To: Subject: [EDI-L] HIPAA 834 Response

Hello, All!

I'm interested in what kind of "responses" have been used to notify
Trading Partners of problems with an 834 Enrollment and Maintenance
request (for business reasons as opposed to EDI errors). I have heard
of a few different approaches:

Send an "Error Report"
Send a "response" 834 to point out the "bad" records
Send an 824

Can anyone give me any feedback on what has "worked" best?

Jeffery McCann
Softshare



To unsubscribe from this group, send an email to:
Message Identifiers: <SALES>, <JOBS>, <LIST>, <TECH>, <MISC>, <EVENT>,
<OFF-TOPIC>
Access the list online at: http://groups.yahoo.com/group/EDI-L


Your use of Yahoo! Groups is subject to
http://docs.yahoo.com/info/terms/





 
EDI to XML Mapping for EDIFACT/X12 Convert EDIFACT/X12 Schemas to XML Schema Legacy Data Conversion Tools Access Relational Data as XML Visual XSLT and XQuery Mapping Tools Simplify EDI Data Integration with Stylus Studio XML Enterprise Suite - Free Download!
Subscribe in XML format
RSS 2.0
Atom 0.3
Site Map | Privacy Policy | Terms of Use | Trademarks
Free Stylus Studio XML Training:
W3C Member
Stylus Studio® and DataDirect XQuery™are products from DataDirect Technologies, is a registered trademark of Progress Software Corporation, in the U.S. and other countries. © 2004-2007 All Rights Reserved.